Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial

被引：0
|
作者：
Roy Fleischmann
Daniel E. Furst
Erin Connolly-Strong
Jingyu Liu
Julie Zhu
Richard Brasington
机构：
[1] University of Texas Southwestern Medical Center,Division of Rheumatology, David Geffen School of Medicine
[2] Metroplex Clinical Research Center,Division of Rheumatology
[3] University of California Los Angeles,undefined
[4] Mallinckrodt Pharmaceuticals,undefined
[5] Washington University School of Medicine,undefined
来源：
Rheumatology and Therapy | 2020年 / 7卷
关键词：
Active disease; Clinical trial; Corticosteroids; Disease-modifying antirheumatic drugs; Low disease activity; Repository corticotropin injection; Rheumatoid arthritis; Withdrawal study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 344
页数：17
相关论文
共 50 条
  • [1] Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
    Fleischmann, Roy
    Furst, Daniel E.
    Connolly-Strong, Erin
    Liu, Jingyu
    Zhu, Julie
    Brasington, Richard
    RHEUMATOLOGY AND THERAPY, 2020, 7 (02) : 327 - 344
  • [2] Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis
    Fleischmann, Roy
    Furst, Daniel E.
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 935 - 944
  • [3] Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
    Bindra, Jas
    Chopra, Ishveen
    Niewoehner, John
    Panaccio, Mary
    Wan, George J.
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 349 - 358
  • [4] Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
    Busch, Howard
    Wan, George J.
    Niewoehner, John
    Houston, Parul
    Su, Yujie
    Clinton, Cassie
    Panaccio, Mary P.
    DRUGS IN CONTEXT, 2022, 11
  • [5] Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
    Roy Fleischmann
    Kyle Hayes
    Sung-Woo Ahn
    George J. Wan
    Mary Panaccio
    Daniel Karlsson
    Daniel E. Furst
    Rheumatology and Therapy, 2022, 9 : 649 - 661
  • [6] Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
    Fleischmann, Roy
    Hayes, Kyle
    Ahn, Sung-Woo
    Wan, George J.
    Panaccio, Mary
    Karlsson, Daniel
    Furst, Daniel E.
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 649 - 661
  • [7] Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
    Fischer, Peter A.
    Rapoport, Ronald J.
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2018, 10 : 13 - 19
  • [8] Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
    Hayes, Kyle
    Panaccio, Mary P.
    Goel, Niti
    Fahim, Mohammed
    RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 327 - 346
  • [9] Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
    Kyle Hayes
    Mary P. Panaccio
    Niti Goel
    Mohammed Fahim
    Rheumatology and Therapy, 2021, 8 : 327 - 346
  • [10] Demographics, treatment patterns, and healthcare utilization and cost of repository corticotropin injection in patients with systemic lupus erythematosus or rheumatoid arthritis
    Wu, Bingcao
    Deshpande, Gaurav
    Gu, Tao
    Popelar, Breanna
    Philbin, Michael
    Wan, George J.
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (11) : 1170 - 1177
12345